[1] ŁUKASIK Z M,MAKOWSKI M,MAKOWSKA J S.From blood coagulation to innate and adaptive immunity:the role of platelets in the physiology and pathology of autoimmune disorders[J].Rheumatol Int,2018,38(6):959-974.
[2] HUONG P T,NGUYEN L T,NGUYEN X B,et al.The role of platelets in the tumor-microenvironment and the drug resistance of cancer cells[J].Cancers (Basel),2019,11(2):240.
[3] OLSSON A K,CEDERVALL J.The pro-inflammatory role of platelets in cancer[J].Platelets,2018,29(6):569-573.
[4] XU X R,YOUSEF G M,NI H.Cancer and platelet crosstalk:opportunities and challenges for aspirin and other antiplatelet agents[J].Blood,2018,131(16):1777-1789.
[5] CHEN W,ZHENG R,BAADE P D,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[6] GASPARYAN A Y,AYVAZYAN L,MIKHAILIDIS D P,et al.Mean platelet volume:a link between thrombosis and inflammation?[J].Curr Pharm Des,2011,17(1):47-58.
[7] SÜRÜCÜ E,DEMIR Y,ŞENGÖZ T.The correlation between the metabolic tumor volume and hematological parameters in patients with esophageal cancer[J].Ann Nucl Med,2015,29(10):906-910.
[8] SUN S Y,ZHAO B Q,WANG J,et al.The clinical implications of mean platelet volume and mean platelet volume/platelet count ratio in locally advanced esophageal squamous cell carcinoma[J].Dis Esophagus,2018,31(2):2.
[9] SHEN W,CUI M M,WANG X,et al.Reduced mean platelet volume is associated with poor prognosis in esophageal cancer[J].Cancer Biomark,2018,22(3):559-563.
[10] FENG J F,SHENG C,ZHAO Q,et al.Prognostic value of mean platelet volume/platelet count ratio in patients with resectable esophageal squamous cell carcinoma:a retrospective study[J].Peer J,2019,7:e7246.
[11] MATSUNAGA T,SAITO H,FUKUMOTO Y,et al.The postoperative platelet distribution width is useful for predicting the prognosis in patients with esophageal squamous cell carcinoma[J].Surg Today,2020,50(2):123-133.
[12] SONG Q,WU J Z,WANG S,et al.Elevated preoperative platelet distribution width predicts poor prognosis in esophageal squamous cell carcinoma[J].Sci Rep,2019,9(1):418-419.
[13] MACHLOWSKA J,BAJ J,SITARZ M,et al.Gastric cancer:epidemiology,risk factors,classification,genomic characteristics and treatment strategies[J].Int J Mol Sci,2020,21(11):4012.
[14] AKSOY E K,KANTARCI S,TORGUTALP M,et al.The importance of complete blood count parameters in the screening of gastric cancer[J].Prz Gastroenterol,2019,14(3):183-187.
[15] 彭柳航,吴辉杰.外周血血小板指标联合血清CEA检测对胃癌和胃溃疡的鉴别诊断作用[J].临床医学工程,2019,26(10):1385-1386.
[16] YUN Z Y,LI N,ZHANG X,et al.Mean platelet volume,platelet distribution width and carcinoembryonic antigen to discriminate gastric cancer from gastric ulcer[J].Oncotarget,2017,8(37):62600-62605.
[17] SUN X J,AI L,FENG Y C.The value of abo blood group and complete blood count for the prognosis analysis of gastric cancer patients[J].Onco Targets Ther,2020,13:4627-4633.
[18] CHENG S,HAN F,WANG Y,et al.The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer[J].BMC Gastroenterol,2017,17(1):163.
[19] SHEN X M,XIA Y Y,LIAN L,et al.Mean platelet volume provides beneficial diagnostic and prognostic information for patients with resectable gastric cancer[J].Oncol Lett,2016,12(4):2501-2506.
[20] ZHU X,CAO Y,LU P,et al.Evaluation of platelet indices as diagnostic biomarkers for colorectal cancer[J].Sci Rep,2018,8(1):26-32.
[21] STOJKOVIC LALOSEVIC M,PAVLOVIC MARKOVIC A,STANKOVIC S,et al.Combined diagnostic efficacy of neutrophil-to-lymphocyte ratio (NLR),platelet-to-lymphocyte ratio (PLR),and mean platelet volume (MPV) as biomarkers of systemic inflammation in the diagnosis of colorectal cancer[J].Dis Markers,2019,2019:6036979.
[22] SAKIN A,SAHIN S,SAKIN A,et al.Mean platelet volume and platelet distribution width correlates with prognosis of early colon cancer[J].J BUON,2020,25(1):227-239.
[23] QIAN W,GE X X,WU J,et al.Prognostic evaluation of resectable colorectal cancer using platelet-associated indicators[J].Oncol Lett,2019,18(1):571-580.
[24] ENGSTRAND J,NILSSON H,STRÖMBERG C,et al.Colorectal cancer liver metastases-a population-based study on incidence,management and survival[J].BMC Cancer,2018,18(1):78.
[25] LI L,HUANG X Y,LI N,et al.Platelet indices in colorectal cancer patients with synchronous liver metastases[J].Gastroenterol Res Pract,2019,2019(4):1-5.
[26] VÄYRYNEN J P,VÄYRYNEN S A,SIRNIÖ P,et al.Platelet count,aspirin use,and characteristics of host inflammatory responses in colorectal cancer[J].J Transl Med,2019,17(1):199.
[27] GARAM N,MALÁTI É,SINKOVITS G,et al.Platelet count,ADAMTS13 activity,von willebrand factor level and survival in patients with colorectal cancer:5-year follow-up study[J].Thromb Haemost,2018,118(1):123-131.
[28] GUO F,ZHU X,QIN X.Platelet distribution width in hepatocellular carcinoma[J].Med Sci Monit,2018,24:2518-2523.
[29] 孙晓洁,刘进,桂霞,等.网织血小板检测在肿瘤化疗所致血小板减少症患者中的应用[J].东南大学学报(医学版),2016,35(6):918-922.
[30] PINTER M,TRAUNER M,PECK-RADOSAVLJEVIC M,et al.Cancer and liver cirrhosis:implications on prognosis and management[J].ESMO Open,2016,1(2):e000042.
[31] SCHEINER B,KIRSTEIN M,POPP S,et al.Association of platelet count and mean platelet volume with overall survival in patients with cirrhosis and unresectable hepatocellular carcinoma[J].Liver Cancer,2019,8(3):203-217.
[32] ZHANG A B,ZHANG Z H,ZHANG J,et al.Lower mean platelet volume is a risk indicator of hepatocellular carcinoma recurrence following liver transplantation[J].Hepatobiliary Pancreat Dis Int,2019,18(3):223-227.
[33] YUE C X,LIU Y X,YUN Z Y,et al.Decreased platelet distribution width predicts a worse prognosis in patients undergoing surgical resection for hepatocellular carcinoma[J].Cancer Biomark,2019,26(3):361-366.
[34] ZUO X,KONG W,FENG L,et al.Elevated platelet distribution width predicts poor prognosis in hepatocellular carcinoma[J].Cancer Biomark,2019,24(3):307-313.
[35] 程娟,管世鹤,陈礼文,等.胰腺癌患者手术前后外周血淋巴细胞亚群和血小板变化[J].检验医学,2020,35(7):655-659.
[36] ULUTAS K T,SARICI I S,ARPACI A.Comparison of platelet distribution width and CA19-9 in resectable pancreas cancer[J].Med Arch,2018,72(3):210-213.
[37] BELLON E,GEBAUER F,TACHEZY M,et al.Pancreatic cancer and liver metastases:state of the art[J].Updates Surg,2016,68(3):247-251.
[38] YIN J B,WANG X,ZHANG X,et al.Mean platelet volume predicts survival in pancreatic cancer patients with synchronous liver metastases[J].Sci Rep,2018,8(1):10-29.
[39] ZHANG K,GAO H F,MO M,et al.A novel scoring system based on hemostatic parameters predicts the prognosis of patients with advanced pancreatic cancer[J].Pancreatology,2019,19(2):346-351.
[40] LEMBECK A L,POSCH F,KLOCKER E V,et al.Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer[J].Clin Chem Lab Med,2019,57(5):740-744.
[41] WANG L,SHENG L,LIU P.The independent association of platelet parameters with overall survival in pancreatic adenocarcinoma receiving intensity-modulated radiation therapy[J].Int J Clin Exp Med,2015,8(11):21215-21221.
[42] RAWLA P,SUNKARA T,THANDRA K C,et al.Epidemiology of gallbladder cancer[J].Clin Exp Hepatol,2019,5(2):93-102.
[43] ZHANG X,NIU Y,WANG X,et al.Mean platelet volume and platelet distribution width are associated with gallbladder cancer[J].Asian Pac J Cancer Prev,2018,19(2):351-355.
[44] WANG R T,ZHANG L Q,MU Y P,et al.Prognostic significance of preoperative platelet count in patients with gallbladder cancer[J].World J Gastroenterol,2015,21(17):5303-5310.
[45] KHAN S A,TAVOLARI S,BRANDI G.Cholangiocarcinoma:epidemiology and risk factors[J].Liver Int,2019,39(Suppl 1):19-31.
[46] LI B,LU J,PENG D Z,et al.Elevated platelet distribution width predicts poor prognosis in hilar cholangiocarcinoma[J].Medicine(Baltimore),2020,99(12):e19400.
[47] WATANABE A,ARAKI K,HIRAI K,et al.A novel clinical factor,D-dimer platelet multiplication,may predict postoperative recurrence and prognosis for patients with cholangiocarcinoma[J].Ann Surg Oncol,2016,23(Suppl 5):886-891. |
